Cargando…
Functional conservation of HIV-1 Gag: implications for rational drug design
BACKGROUND: HIV-1 replication can be successfully blocked by targeting gag gene products, offering a promising strategy for new drug classes that complement current HIV-1 treatment options. However, naturally occurring polymorphisms at drug binding sites can severely compromise HIV-1 susceptibility...
Autores principales: | Li, Guangdi, Verheyen, Jens, Rhee, Soo-Yon, Voet, Arnout, Vandamme, Anne-Mieke, Theys, Kristof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228425/ https://www.ncbi.nlm.nih.gov/pubmed/24176092 http://dx.doi.org/10.1186/1742-4690-10-126 |
Ejemplares similares
-
HIV-1 Gag C-terminal amino acid substitutions emerging under selective pressure of protease inhibitors in patient populations infected with different HIV-1 subtypes
por: Li, Guangdi, et al.
Publicado: (2014) -
An integrated map of HIV genome-wide variation from a population perspective
por: Li, Guangdi, et al.
Publicado: (2015) -
A new ensemble coevolution system for detecting HIV-1 protein coevolution
por: Li, Guangdi, et al.
Publicado: (2015) -
Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance
por: Cuypers, Lize, et al.
Publicado: (2015) -
Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development
por: Cuypers, Lize, et al.
Publicado: (2016)